Eevia Health Plc receiveS A 473k sek (42K USD) sales order for Feno-Sambucus™ 7 Organic
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Eevia Health Plc receiveS A 473k sek (42K USD) sales order for Feno-Sambucus™ 7 Organic.

Eevia Health ("Eevia" or "The Company") received a 473K SEK / 42K USD sales order for the elderberry extract Feno-Sambucus™ 7 Organic from a distributor in the US.

The order is from Select Ingredients, a distributor located in San Diego, California, US. Select Ingredients is a specialist in organic ingredients and high-quality natural plant extracts, serving branded customers in the Golden State and other large states in the US.

The end customer is a brand owner that specializes in organic plant-based food supplements without sugars and artificial compounds. The end customer provides supplements skews for the whole family. This is a repeat order for FENO-SAMBUCUS™ 7 Organic and they are expected to place more repeat orders in the future. The end customer chose Eevia due to its quality and ingredient profile.

Eevia Health is currently the largest manufacturer of elderberry extract in the world. FENO-SAMBUCUS™ 7 Organic is a certified organic elderberry extract standardized at 7% anthocyanins. Eevia Health's superior extraction and purification technology provides for a superior bioactive and nutritional profile. Eevia uses a special purification technology that purifies the product based on chemical class and not molecular size. This process leaves other important bioactive compounds present in the extract, such as oligomeric proanthocyanidins (OPCs), which provide a better nutritional profile than competitors.

 

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]                      

Telephone: +358 400 22 5967                         

 

 

 

 

 

 

 

 

 

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth. 

 

Bifogade filer

Press release per August 14 2023 Eevia Health Plc order for Feno-Sambucus 7https://mb.cision.com/Main/20679/3817033/2226290.pdf

Nyheter om Eevia Health

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Eevia Health

Senaste nytt